Global Blood Testing Market Size and Overview
The Global Blood Testing Market was valued at USD 96.8 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030, reaching an estimated USD 141.8 billion by 2030.
Blood testing plays a critical role in disease diagnosis, patient monitoring, preventive healthcare, and therapeutic management. It is one of the most widely performed diagnostic procedures worldwide and serves as the foundation for clinical decision-making across a range of healthcare settings. The market encompasses multiple test types, including glucose monitoring, lipid profiling, thyroid assessment, infectious disease detection, and hormone level evaluation. Rising awareness of early disease diagnosis, expanding diagnostic infrastructure, and increasing adoption of automated testing technologies are driving the growth of this sector. Preventive health checkups, chronic disease management programs, and the integration of advanced molecular technologies have further increased testing volumes globally. Additionally, growing investments in laboratory automation, development of next-generation testing devices, and emphasis on personalised healthcare approaches are expected to enhance market penetration over the forecast period.
Key Market Insights
Glucose tests and lipid panel tests account for more than 35% of the global test volume due to their widespread use in chronic disease management.
Automated testing methods make up over 60% of the market, driven by laboratory modernisation and rapid result delivery.
Reagents and kits represent more than 50% of revenue share, indicating their recurring demand in diagnostic workflows.
Nucleic acid testing and ELISA/CLIA remain dominant technologies for infectious disease and biomarker testing.
Hospitals and diagnostic laboratories together account for nearly 70% of the end-user base, reflecting centralised testing dominance.
North America holds over 35% of the global market share due to high testing rates and advanced infrastructure.
Rapid expansion of preventive health programs in the Asia-Pacific is expected to boost test volumes significantly over the forecast period.
In September 2025, startup Nutromics built a “lab-on-a-patch” wearable diagnostic device that uses DNA-based biosensors to continuously monitor multiple health markers, aiming to replace traditional blood draws in some diagnostic settings.
Global Blood Testing Market Drivers
The rising global burden of chronic and infectious diseases is driving the market growth.
The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and thyroid dysfunction has fueled the need for regular blood testing worldwide. Glucose, lipid panel, and A1C tests are central to the management and monitoring of diabetes, which affects hundreds of millions globally. Cardiovascular disease remains one of the leading causes of death, and early detection through lipid panel and biomarker testing has become an essential public health strategy. In addition to chronic conditions, infectious diseases such as hepatitis, HIV, tuberculosis, and emerging viral infections require accurate and rapid testing for early intervention and containment. Blood testing remains one of the most efficient diagnostic methods for detecting these diseases at scale. The increasing emphasis on early screening programs, population-based diagnostics, and preventive healthcare further expands testing demand. Governments and healthcare systems worldwide are investing in large-scale screening initiatives, which directly increase testing volumes and expand laboratory capacity. Additionally, awareness among individuals regarding preventive checkups and wellness testing is higher than ever before, reinforcing market expansion.
Technological advancements and rapid automation of laboratories are driving the market growth.
Technological innovation plays a central role in transforming the blood testing landscape. Automated testing instruments and robotics have significantly reduced turnaround times and improved the accuracy and reliability of results. Modern analysers can process thousands of samples per hour, enabling laboratories to handle high testing volumes efficiently. Integration of AI-driven quality control systems and real-time monitoring ensures consistency and minimises manual errors. Molecular testing technologies, including NAT and NGS, have expanded the diagnostic capabilities of laboratories, enabling the detection of complex genetic and infectious conditions. Point-of-care solutions have also gained traction, allowing testing in clinics and home care settings, thereby increasing accessibility. Automation reduces the dependency on skilled labour, making testing scalable even in regions with limited healthcare personnel. Furthermore, interoperability between laboratory information systems and hospital records is improving operational efficiency. With continued investment in smart diagnostics and connected devices, testing workflows are expected to become faster, more cost-effective, and more patient-centric in the coming years.
Global Blood Testing Market Challenges and Restraints
High costs and limited access to advanced testing in low-resource settings are restricting the market growth.
Despite rapid technological advancements, the cost of implementing and maintaining advanced blood testing infrastructure remains a major challenge, particularly in developing and low-income countries. Automated analysers, molecular testing platforms, and high-quality reagents require significant capital investment, making it difficult for small laboratories and rural healthcare facilities to adopt these solutions. Additionally, the recurring costs associated with quality assurance, calibration, maintenance, and consumables contribute to the financial burden. Many regions also face shortages of trained laboratory personnel capable of operating sophisticated equipment and ensuring result accuracy. Limited reimbursement policies, out-of-pocket expenses, and lack of insurance coverage for preventive testing further restrict access in these markets. This economic divide creates unequal availability of testing, affecting early disease detection and population health management. While donor-funded programs and government initiatives attempt to bridge this gap, sustainable access remains a concern. Overcoming these costs and infrastructure barriers will be crucial to achieving equitable testing coverage globally.
Global Blood Testing Market Opportunities
The blood testing market presents substantial growth opportunities driven by the convergence of technological innovation, expanding healthcare infrastructure, and the increasing global focus on preventive health. One of the strongest opportunities lies in the further expansion of decentralised testing models. The rising adoption of point-of-care devices and at-home testing kits can bring diagnostic access closer to patients, especially in remote or underserved areas. The integration of wearable technologies and connected devices into healthcare ecosystems also offers prospects for continuous monitoring and personalised health management. Growing investments in molecular diagnostics and advanced biomarker discovery enable the development of more precise, rapid, and minimally invasive tests. Emerging economies are witnessing accelerated healthcare modernisation, creating new market entry and expansion pathways for global testing companies. Furthermore, the rise of digital health platforms, telemedicine integration, and AI-driven diagnostic support will enhance efficiency and patient engagement. Strategic collaborations between public health agencies, diagnostic manufacturers, and technology firms can help overcome infrastructure gaps and improve affordability. In addition, increased demand for personalised medicine and companion diagnostics is likely to stimulate new test development and drive innovation. As health systems prioritise early detection and value-based care, the demand for comprehensive blood testing solutions is expected to continue its upward trajectory through the forecast period.
BLOOD TESTING MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2024 - 2030 |
|
Base Year |
2024 |
|
Forecast Period |
2025 - 2030 |
|
CAGR |
6.5% |
|
Segments Covered |
By Test Type, By Method, By Components, By Technology, By Disease, By End User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Danaher Corporation, Thermo Fisher Scientific, Quest Diagnostics, Beckman Coulter, Ortho Clinical Diagnostics, Sysmex Corporation |
Global Blood Testing Market Segmentation
Global Blood Testing Market By Test Type
• Glucose tests
• Lipid panel tests
• A1C (glycated haemoglobin) tests
• Thyroid Stimulating Hormone (TSH) tests
• Prostate-Specific Antigen (PSA) tests
• Vitamin D tests
• CRP (C-reactive protein) tests
• ALT / AST (liver enzymes) tests
• BUN (blood urea nitrogen) tests
• Others
Glucose testing is the most dominant segment in the blood testing market due to the global prevalence of diabetes and the critical need for regular monitoring. Millions of patients rely on routine glucose checks to manage their condition effectively. This segment benefits from both laboratory-based and point-of-care testing solutions, making it accessible and scalable. Rising awareness of lifestyle-related health risks, government health initiatives, and the availability of affordable glucose testing devices are further contributing to its leadership in the market. Its integration with digital health platforms and home monitoring devices has increased its reach, making it one of the most widely performed tests worldwide.
Global Blood Testing Market By Method
• Manual testing methods
• Automated blood testing methods
Automated testing methods dominate the market due to their ability to deliver accurate and rapid results while handling large sample volumes. Laboratories are increasingly adopting automated analysers and robotics to improve operational efficiency and minimise human error. Automation supports standardisation, reduces turnaround time, and enhances throughput, which is essential in high-demand environments such as hospitals and diagnostic laboratories. As healthcare infrastructure modernises globally, automated solutions are expected to capture an even greater share, particularly in high-volume testing centres and urban healthcare settings.
Global Blood Testing Market By Components
• Reagents & kits
• Instruments/equipment
• Software & services
Reagents and kits represent the largest component segment because they are consumables and essential for each test performed, leading to recurring revenue streams. They form the backbone of most laboratory testing operations and are required regardless of the level of automation. Increased testing volumes, the expansion of disease screening programs, and frequent repeat testing in chronic conditions contribute to their dominant position in the market. Manufacturers are also introducing specialised reagents compatible with advanced analysers, strengthening this segment’s growth outlook.
Global Blood Testing Market By Technology
• Nucleic Acid Testing (NAT)
• ELISA, CLIA, etc. (serology tests)
• Next‐Generation Sequencing (NGS)
• Western blot, Rapid tests, Others
ELISA and CLIA-based serology tests dominate the technology segment due to their wide application in infectious disease screening, hormone level evaluation, and general health assessments. These methods are well-established, cost-effective, and suitable for both centralised and decentralised laboratory settings. Their proven reliability and compatibility with automation systems make them ideal for large-scale testing. Nucleic acid testing and NGS are expanding rapidly, but serology remains the most widely used testing technology worldwide.
Global Blood Testing Market By Disease
• Infection
• Anemia
• Leukemia/cancers
• Endocrine / metabolic disorders (e.g. diabetes, thyroid)
Endocrine and metabolic disorders are the most significant disease segment, primarily because of the global rise in diabetes and thyroid disorders. Regular glucose and hormone level monitoring is essential for disease management, prevention of complications, and improved quality of life. The segment benefits from strong reimbursement support, government screening programs, and accessible testing technologies. Growing lifestyle-related health concerns and awareness further reinforce the dominance of this disease category in the global testing landscape.
Global Blood Testing Market By End User
• Hospitals
• Diagnostic / Clinical Laboratories / Diagnostic Centres
• Clinics
• Research labs
• Blood banks/blood screening organisations
Hospitals represent the largest end-user segment due to their central role in patient diagnosis, treatment planning, and emergency care. They maintain high testing volumes through both routine screenings and specialised diagnostic procedures. Hospitals often operate advanced laboratory infrastructure with automated analysers and employ skilled laboratory professionals, ensuring efficient workflows. Their capacity to handle high patient inflows and complex cases secures their dominant share in the market.
Global Blood Testing Market Regional Segmentation
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
North America remains the dominant region in the blood testing market, accounting for more than one-third of the global share. The region benefits from highly advanced healthcare infrastructure, extensive insurance coverage, and widespread availability of diagnostic services. The United States, in particular, has high testing volumes driven by preventive care programs, chronic disease management initiatives, and frequent health checkups. Adoption of cutting-edge technologies, strong regulatory frameworks, and early integration of AI and automation give the region a competitive advantage. Furthermore, the presence of leading diagnostic companies, a robust distribution network, and continuous innovation in laboratory systems support sustained market leadership. Canada also contributes significantly through its universal healthcare approach, ensuring equitable access to testing. The region’s strong emphasis on wellness and early detection further reinforces its position as a global leader in blood testing services.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly accelerated demand for blood testing services globally. While initial disruptions in supply chains and elective procedures affected testing volumes in early 2020, the widespread implementation of COVID-related serological and molecular testing drove substantial market growth. Blood tests became essential for detecting infection, monitoring immune responses, and identifying inflammation markers associated with severe disease. Laboratories rapidly scaled up capacity, adopted automation, and implemented high-throughput systems to meet testing demands. In addition to COVID-specific tests, the pandemic increased public awareness of preventive healthcare, leading to a surge in routine health checkups after restrictions eased. Investments in diagnostic infrastructure expanded globally, improving accessibility and laboratory capabilities, particularly in developing countries. The experience also accelerated the adoption of digital tools, remote consultations, and point-of-care testing, which remain relevant post-pandemic. Overall, COVID-19 acted as a catalyst for modernisation, resilience, and growth in the blood testing market, with many innovations continuing to shape the industry in the years ahead.
Latest Trends/Developments
The blood testing market is experiencing several transformative trends. The rise of point-of-care testing and home-based diagnostic solutions is increasing patient access and convenience, enabling faster diagnosis and improved disease monitoring. Wearable devices integrated with biosensors are enabling real-time health insights, enhancing preventive healthcare strategies. Automation and digitalisation remain central trends, with AI-powered platforms improving diagnostic accuracy, reducing errors, and streamlining workflows. Advanced molecular testing technologies like NGS and NAT are expanding the scope of testing to include genetic profiling and early cancer detection. Industry players are focusing on developing multiplexed assays capable of detecting multiple biomarkers from a single sample, improving efficiency and cost-effectiveness. In addition, sustainability considerations are leading to the introduction of eco-friendly consumables and energy-efficient laboratory systems. Strategic partnerships between diagnostic companies, tech firms, and healthcare providers are accelerating product innovation and market expansion. These developments collectively signal a shift toward personalised, accessible, and efficient testing ecosystems, setting the stage for future market growth.
Global Blood Testing Market Key Players
Market News
In February, 2025, Hims & Hers Health shares hit a record high following its acquisition of Trybe Labs, enabling the company to introduce at-home blood testing services for markers like cholesterol, hormone levels, thyroid, etc.
In April, 2025, Labcorp announced its Q1 2025 results, introduced new blood tests, including a liquid biopsy test for cancer and a pTau-217/Beta Amyloid 42 Ratio test for Alzheimer’s disease diagnosis, reinforcing its strategy to expand in oncology, women’s health, autoimmune disease, and neurology.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The market was valued at USD 96.8 billion in 2024 and is expected to reach USD 141.8 billion by 2030, growing at a CAGR of 6.5%.
Key drivers include the growing burden of chronic and infectious diseases and the rapid adoption of automated testing technologies.
Segments include Test Type, Method, Components, Technology, Disease, End User, and Region.
North America dominates due to advanced infrastructure, high testing rates, and early adoption of innovative technologies.
Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Danaher, and others.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
